NASDAQ:CYTH - Nasdaq - US23254X2018 - Common Stock - Currency: USD
TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 870.72K | 1.08M | 1.38M | 1.59M | 900.00K | |||
Cost Of Goods | 76.25K | 98.46K | 150.00K | 170.00K | 70.00K | |||
Gross Profit | 794.47K | 977.95K | 1.23M | 1.42M | 830.00K | |||
Operating Expenses | 25.47M | 21.03M | 16.85M | 15.71M | 9.79M | |||
Research and Development | 15.97M | 14.18M | 9.00M | 9.15M | 6.10M | |||
Selling, General, and Administrative Expenses | 9.49M | 6.83M | 7.83M | 6.54M | 3.68M | |||
Operating Income | -24.68M | -20.05M | -15.62M | -14.29M | -8.96M | |||
Interest Income/Expense | 591.42K | -7.25K | 10.00K | 0.00 | 20.00K | |||
Non Recurring Items | -11.81K | 0.00 | 160.00K | N/A | 0.00 | |||
Income Before Taxes | -24.80M | -20.06M | -15.45M | -14.29M | -8.94M | |||
Income Tax | N/A | N/A | 0.00 | 0.00 | N/A | |||
Net Income | -24.80M | -20.06M | -15.45M | -14.29M | -8.94M | |||
EBITDA | -24.67M | -20.03M | -15.60M | -14.27M | -8.95M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -0.92 | -1.23 | -1.83 | -2.24 | -5.59 | |||
Non GAAP EPS | N/A | N/A | -1.83 | -2.30 | N/A | |||
Statistics | ||||||||
Gross Profit Margin | 91.24% | 90.85% | 89.13% | 89.31% | 92.22% | |||
Profit Margin | -2848.18% | -1863.35% | -1119.57% | -898.74% | -993.33% | |||
Operating Profit Margin | -2834.08% | -1862.68% | -1131.88% | -898.74% | -995.56% |
All data in USD